O tratamento atual da hiperhidrose
Current treatment of hyperhidrosis
Nelson Wolosker, Juliana Maria Fukuda
References
1. Lear W, Kessler E, Solish N, Glaser DA. An epidemiological study of hyperhidrosis. Dermatol Surg. 2007;33(1 Spec No.):S69-75. http:// dx.doi.org/10.1111/j.1524-4725.2006.32334.x. PMid:17241417.
2. Campos JRM, Kauffman P, Werebe EC, et al. Quality of life, before and after thoracic sympathectomy: report on 378 operated patients. Ann Thorac Surg. 2003;76(3):886-91. http://dx.doi.org/10.1016/ S0003-4975(03)00895-6. PMid:12963223.
3. Bushara KO, Park DM, Jones JC, Schutta HS. Botulinum toxin: a possible new treatment for axillary hyperhidrosis. Clin Exp Dermatol. 1996;21(4):276-8. http://dx.doi.org/10.1111/j.1365-2230.1996. tb00093.x. PMid:8959898.
4. LeWitt P. Hyperhidrosis and hypothermia responsive to oxybutynin. Neurology. 1988;38(3):506-7. http://dx.doi.org/10.1212/ WNL.38.3.506-a. PMid:3347362.
5. Wolosker N, Campos JR, Kauffman P, et al. An alternative to treat palmar hyperhidrosis: use of oxybutynin. Clin Auton Res. 2011;21(6):389-93. http://dx.doi.org/10.1007/s10286-011-0128-4. PMid:21688168.
6. Wolosker N, Campos JRM, Kauffman P, Yazbek G, Neves S, PuechLeão P. Use of oxybutynin for treating plantar hyperhidrosis. Int J Dermatol. 2013;52(5):620-3. http://dx.doi.org/10.1111/j.1365- 4632.2012.05746.x. PMid:23590378.
7. Wolosker N, Campos JRM, Kauffman P, et al. The use of oxybutynin for treating axillary hyperhidrosis. Ann Vasc Surg. 2011;25(8):1057- 62. http://dx.doi.org/10.1016/j.avsg.2011.06.007. PMid:22023940.
8. Wolosker N, Campos JRM, Kauffman P, et al. The use of oxybutynin for treating facial hyperhidrosis. An Bras Dermatol. 2011;86(3):451-6. http://dx.doi.org/10.1590/S0365-05962011000300005. PMid:21738960.
9. Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of oxybutynin treatment for palmar hyperhidrosis. Clin Auton Res. 2014;24(6):297-303. http://dx.doi.org/10.1007/s10286-014-0264-8. PMid:25427685.
10. Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of the use of oxybutynin for the treatment of plantar hyperhidrosis. Int J Dermatol. 2015;54(5):605-11. http://dx.doi.org/10.1111/ ijd.12729. PMid:25600990.
11. Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of the use of oxybutynin for the treatment of axillary hyperhidrosis. Ann Vasc Surg. 2014;28(5):1106-12. http://dx.doi.org/10.1016/j. avsg.2013.12.024. PMid:24512855.
12. Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of oxybutynin use in treating facial hyperhidrosis. An Bras Dermatol. 2014;89(6):912-6. http://dx.doi.org/10.1590/abd1806-4841.20143272. PMid:25387496.
13. Yoshida WB, Cataneo DC, Bomfim GAZ, Hasimoto E, Cataneo AJM. Chemical lumbar sympathectomy in plantar hyperhidrosis. Clin Auton Res. 2010;20(2):113-5. http://dx.doi.org/10.1007/ s10286-009-0047-9. PMid:20012143.
14. Wolosker N, Campos JRM, Kauffman P, Oliveira LA, Munia MAS, Jatene FB. Evaluation of quality of life over time among 453 patients with hyperhidrosis submitted to endoscopic thoracic sympathectomy. J Vasc Surg. 2012;55(1):154-6. http://dx.doi. org/10.1016/j.jvs.2011.07.097. PMid:22047833.
15. Kux E. 1239 Cases of thorascopic sympathectomy and vagotomy; preliminary report. Dtsch Med Wochenschr. 1953;78(46):1590-2. http://dx.doi.org/10.1055/s-0028-1115011. PMid:13107399.
16. Andrade LO Fo, Kuzniec S, Wolosker N, Yazbek G, Kauffman P, Campos JRM. Technical difficulties and complications of sympathectomy in the treatment of hyperhidrosis: an analysis J Vasc Bras. 2015 Oct.-Dec.; 14(4):279-281 281 Nelson Wolosker, Juliana Maria Fukuda of 1731 cases. Ann Vasc Surg. 2013;27(4):447-53. http://dx.doi. org/10.1016/j.avsg.2012.05.026. PMid:23406790.
17. Lyra R M, Campos JR, Kang DW, et al. Guidelines for the prevention, diagnosis and treatment of compensatory hyperhidrosis. J Bras Pneumol. 2008;34(11):967-77. PMid:19099105.
18. Campos JRM, Wolosker N, Takeda FR, et al. The body mass index and level of resection: predictive factors for compensatory sweating after sympathectomy. Clin Auton Res. 2005;15(2):116-20. http:// dx.doi.org/10.1007/s10286-005-0259-6. PMid:15834768.
19. Sugimura H, Spratt EH, Compeau CG, Kattail D, Shargall Y. Thoracoscopic sympathetic clipping for hyperhidrosis: long-term results and reversibility. J Thorac Cardiovasc Surg. 2009;137(6):1370- 6. http://dx.doi.org/10.1016/j.jtcvs.2009.01.008. PMid:19464450.
20. Haam SJ, Park SY, Paik HC, Lee DY. Sympathetic nerve reconstruction for compensatory hyperhidrosis after sympathetic surgery for primary hyperhidrosis. J Korean Med Sci. 2010;25(4):597-601. http://dx.doi.org/10.3346/jkms.2010.25.4.597. PMid:20358004.
21. Teivelis MP, Wolosker N, Krutman M, Campos JRM, Kauffman P, Puech-Leão P. Compensatory hyperhidrosis: results of pharmacologic treatment with oxybutynin. Ann Thorac Surg. 2014;98(5):1797-802. http://dx.doi.org/10.1016/j.athoracsur.2014.05.087. PMid:25173719.
22. Kao MC. Thoracoscopic sympathectomy for craniofacial hyperhidrosis. Eur J Cardiothorac Surg. 2001;19(6):951-2. http:// dx.doi.org/10.1016/S1010-7940(01)00729-1. PMid:11482300.
23. Ishy A, Campos JRM, Wolosker N, et al. Objective evaluation of patients with palmar hyperhidrosis submitted to two levels of sympathectomy: T3 and T4. Interact Cardiovasc Thorac Surg. 2011;12(4):545-8. http://dx.doi.org/10.1510/icvts.2010.252015. PMid:21233258.
24. Munia MAS, Wolosker N, Kaufmann P, Campos JRM, PuechLeão P. Sustained benefit lasting one year from T4 instead of T3-T4 sympathectomy for isolated axillary hyperhidrosis. Clinics. 2008;63(6):771-4. http://dx.doi.org/10.1590/S1807-59322008000600011. PMid:19060999.